Abstract Background The association between Apolipoprotein A5 (APOA5) genetic
polymorphisms and susceptibility to metabolic syndrome (MetS) has been established by …

The Tehran cardiometabolic genetic study (TCGS) is a large population-based cohort study
that conducts periodic follow-ups. TCGS has created a comprehensive database comprising …

The purpose of this study was to investigate genetic factors associated with metabolic
syndrome (MetS) by conducting a large-scale genome-wide association study (GWAS) in …

The APOA1/C3/A4/A5 cluster is an essential component in regulating lipoprotein
metabolism and maintaining plasma lipid homeostasis. A genome-wide association analysis …

Background and aim Metabolic syndrome (MetS) increases the risk of atherosclerosis and
diabetes, but there are no approved predictive markers. This study assessed the role of …

Background Coronary heart disease (CHD) and type 2 diabetes (T2D) are two complex
diseases with complex interrelationships. However, the genetic architecture of the two …

Background Consumption of dietary fiber has been suggested as an important aspect of a
healthy diet to reduce the risk of metabolic syndrome (MetS), including cardiovascular …

Background Specific biomarkers for metabolic syndrome (MetS) may improve diagnostic
specificity for clinical information. One of the main pathophysiological mechanisms of MetS …

Objective: Metabolic syndrome (MetS) is a complex multifactorial disorder that considerably
burdens healthcare systems. We aim to classify MetS using regularized machine learning …

Background The apolipoprotein A5 (APOA5) gene has been identified as a key regulatory
factor in triglyceride (TG) metabolism and plasma lipid levels. Genetic polymorphisms of …